Joshua D. Palmer

6.5k total citations · 1 hit paper
189 papers, 2.7k citations indexed

About

Joshua D. Palmer is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Joshua D. Palmer has authored 189 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Genetics, 92 papers in Pulmonary and Respiratory Medicine and 52 papers in Epidemiology. Recurrent topics in Joshua D. Palmer's work include Glioma Diagnosis and Treatment (101 papers), Brain Metastases and Treatment (73 papers) and Meningioma and schwannoma management (46 papers). Joshua D. Palmer is often cited by papers focused on Glioma Diagnosis and Treatment (101 papers), Brain Metastases and Treatment (73 papers) and Meningioma and schwannoma management (46 papers). Joshua D. Palmer collaborates with scholars based in United States, Canada and Italy. Joshua D. Palmer's co-authors include Nicholas G. Zaorsky, Wenyin Shi, Haley K. Perlow, Maria Werner‐Wasik, Pierre Giglio, Iyad Alnahhas, Vinay K. Puduvalli, Jon Glass, Daniel M. Trifiletti and David W. Andrews and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Joshua D. Palmer

165 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liquid biopsies: the future of cancer early detection

2023 187 citations Joshua D. Palmer, Haley K. Perlow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joshua D. Palmer United States	26	1.1k	1.0k	623	561	428	189	2.7k
Tony J. C. Wang United States	27	1.2k 1.1×	858 0.9×	549 0.9×	555 1.0×	421 1.0×	114	2.5k
Jiayi Huang United States	33	963 0.9×	969 1.0×	830 1.3×	796 1.4×	411 1.0×	193	3.3k
Sara Erridge United Kingdom	24	990 0.9×	1.7k 1.6×	515 0.8×	674 1.2×	485 1.1×	67	3.0k
Rakesh Jalali India	26	648 0.6×	1.0k 1.0×	406 0.7×	490 0.9×	605 1.4×	147	2.4k
Jian Campian United States	30	625 0.6×	931 0.9×	1.2k 1.9×	481 0.9×	343 0.8×	117	2.8k
Seema Nagpal United States	27	1.1k 1.0×	1.0k 1.0×	828 1.3×	432 0.8×	418 1.0×	129	2.8k
Annika Malmström Sweden	21	720 0.7×	1.2k 1.2×	664 1.1×	533 1.0×	785 1.8×	66	2.3k
Nils D. Arvold United States	26	1.5k 1.4×	1.1k 1.1×	1.3k 2.2×	605 1.1×	709 1.7×	67	3.3k
Stephanie L. Pugh United States	20	1.3k 1.2×	1.0k 1.0×	609 1.0×	197 0.4×	164 0.4×	94	2.3k
Gaetano Lanzetta Italy	27	2.1k 1.9×	2.1k 2.1×	906 1.5×	435 0.8×	253 0.6×	80	3.5k

Countries citing papers authored by Joshua D. Palmer

Since Specialization

Citations

This map shows the geographic impact of Joshua D. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua D. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua D. Palmer more than expected).

Fields of papers citing papers by Joshua D. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua D. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua D. Palmer. The network helps show where Joshua D. Palmer may publish in the future.

Co-authorship network of co-authors of Joshua D. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua D. Palmer. A scholar is included among the top collaborators of Joshua D. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua D. Palmer. Joshua D. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Upadhyay, Rituraj, Brett Klamer, Raj Singh, et al.. (2025). Local Control and Toxicity Outcomes After Stereotactic Body Radiation Therapy for Metastatic Osteosarcoma in Pediatric Patients. Pediatric Blood & Cancer. 72(9). e31834–e31834.

Ward, Jacob, et al.. (2025). Evaluation of fusion status in patients with minimum 1-year survival postoncologic spinal fusion. The Spine Journal. 25(11). 2545–2552.

Sun, Kai, Søren M. Bentzen, Paul D. Brown, et al.. (2025). Redefining neurocognitive outcomes after radiation for brain metastases: a patient-level meta-analysis of recovery following initial decline. JNCI Journal of the National Cancer Institute. 118(2). 269–275.

Matsui, Jennifer K., David L. Swanson, Pamela Allen, et al.. (2025). Reduced Treatment Volumes for Glioblastoma Associated With Lower Rates of Radionecrosis and Lymphopenia: A Pooled Analysis. Advances in Radiation Oncology. 10(3). 101717–101717.

Yang, Zhaozhi, Jin Meng, Xin Mei, et al.. (2024). Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases. JAMA Oncology. 10(3). 335–335. 10 indexed citations

Tom, Martin C., Seema Nagpal, Joshua D. Palmer, et al.. (2024). An update to the American Radium Society’s appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors. Radiotherapy and Oncology. 202. 110640–110640.

Baliga, Sujith, Samir Patel, Issam El Naqa, et al.. (2023). Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 119(2). 610–624. 8 indexed citations

Diawara, Norou, et al.. (2023). Prediction of Rapid Early Progression and Survival Risk with Pre-Radiation MRI in WHO Grade 4 Glioma Patients. Cancers. 15(18). 4636–4636. 6 indexed citations

Cherry, Daniel, Daniel R. Dickstein, Robert Samstein, et al.. (2023). The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancer. Chinese Clinical Oncology. 12(4). 44–44. 1 indexed citations

10.

Lazow, Margot, Kathleen M. Schieffer, Joshua D. Palmer, et al.. (2023). DIPG-51. ABDOMINAL METASTASES OF DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED WITH A VENTRICULOPERITONEAL SHUNT. Neuro-Oncology. 25(Supplement_1). i24–i25.

11.

Barbour, Andrew B., Rupesh Kotecha, Stanislav Lazarev, et al.. (2023). Radiation Therapy in the Management of Leptomeningeal Disease From Solid Tumors. Advances in Radiation Oncology. 9(2). 101377–101377. 5 indexed citations

12.

Baliga, Sujith, Jennifer K. Matsui, Brett Klamer, et al.. (2022). Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. British Journal of Radiology. 95(1133). 20211088–20211088. 3 indexed citations

13.

Blakaj, Dukagjin, Joshua D. Palmer, Eric C. Bourekas, et al.. (2020). Postoperative Stereotactic Body Radiotherapy for Spinal Metastasis and Predictors of Local Control. Neurosurgery. 88(5). 1021–1027. 15 indexed citations

14.

Palmer, Joshua D., Deepak Bhamidipati, Minesh P. Mehta, et al.. (2018). Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus. Journal of Neuro-Oncology. 140(2). 421–426. 19 indexed citations

15.

Palmer, Joshua D., Deepak Bhamidipati, Andrew Song, et al.. (2018). Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?. Journal of Neuro-Oncology. 140(3). 623–628. 31 indexed citations

16.

Sun, Yunguang, Joshua D. Palmer, Charalambos Solomides, et al.. (2017). IGFBP3 Modulates Lung Tumorigenesis and Cell Growth through IGF1 Signaling. Molecular Cancer Research. 15(7). 896–904. 41 indexed citations

17.

Zaorsky, Nicholas G., Joshua D. Palmer, Mark Hurwitz, et al.. (2015). What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation. Radiotherapy and Oncology. 115(3). 295–300. 90 indexed citations

18.

Yeung, Vincent, Joshua D. Palmer, Noelle L. Williams, et al.. (2015). Adenosquamous Carcinoma of the Pancreas in a Patient with BRCA2 Mutation: A Case Report. PubMed. 1(1). 22–25. 2 indexed citations

19.

Williams, Noelle L., Joshua D. Palmer, Voichita Bar‐Ad, et al.. (2015). Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the Literature. PubMed. 1(1). 3–6. 11 indexed citations

20.

Yamoah, Kosj, Harriet Eldredge-Hindy, Nicholas G. Zaorsky, et al.. (2014). Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 13(5). 456–464. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact